Ir al contenido
· Rellenos dérmicos
SKU 11119

Revanesse Versa™+

En stock
Volumen
2 x 1,2 mL
Laboratorio
Prollenium Medical Technologies Inc.
Origen
Canadá
Indicación
Facial line smoothing and volume enhancement
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

Revanesse Versa™+ is a hyaluronic acid injectable by Prollenium Medical Technologies, developed to correct facial wrinkles and folds that are moderate to severe. Qualified medical professionals use it in adults aged 22 years and older to treat facial wrinkles and folds, for example nasolabial folds. The product contains 25 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine and is intended for professional use. It comes in pre-filled syringes, including a 1.2 mL configuration, and is FDA approved in the United States.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

Principales ventajas de Revanesse Versa™+

  • Bioresorbable cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
  • Indicated for moderate to severe facial wrinkles and folds, such as nasolabial folds
  • Placed in the mid to deep dermis
  • FDA approved for the cosmetic treatment of facial wrinkles and creases
  • Supported by a randomised, multicentre, double-blind split-face study of 100 patients
  • Delivered in pre-filled disposable glass syringes, two 1.2 mL per box with two sterile needles
Información clave
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origen Canada
Certificación FDA approved
Composición Bioresorbable cross-linked hyaluronic acid 25 mg/mL containing 0.3% lidocaine
Volumen / Tamaño 1.2 ml
Envase 2 pre-filled disposable glass syringes x 1.2 mL, with two sterile needles
Tipo de uso Professional use only - injectable dermal filler for facial wrinkle smoothing, in patients 22 years of age and older
Profundidad de inyección Mid to deep dermis. Intended for intradermal use only and must not be injected into blood vessels.

Indicaciones y uso profesional

Indicaciones principales

  • Correction of moderate to severe facial wrinkles and folds
  • Nasolabial folds

Uso profesional

For professional use. Revanesse Versa+ is injected by qualified, trained doctors into the dermis of the patient, and is not for retail sale or self-administration. It is intended for intradermal use only and must not be injected into blood vessels: unintentional intravascular injection is rare but its complications can be serious and may be permanent, including vision abnormalities, blindness, stroke, temporary scabs and permanent scarring of the skin. Stop immediately and seek specialist assessment if the patient shows changes in vision, signs of a stroke, white appearance of the skin, or unusual pain during or shortly after treatment. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing, and confirm the box seal is unbroken and the product in date before use.

Zonas de tratamiento

  • Face
  • Nasolabial folds

Perfil del paciente

Indicated for adults 22 years of age or more seeking correction of moderate to severe facial wrinkles and folds. It should not be used in patients who are pregnant or breastfeeding, as safety in these groups has not been studied; who have a history of hypertrophic scarring or keloid formation; who have evidence of scars at the intended treatment sites; who have acne or other inflammatory skin diseases such as rosacea, seborrhoeic dermatitis or psoriasis; or who have an allergic history including severe allergic reactions, atopy, allergy to hyaluronic acid products, or allergy to streptococcal proteins. Treatment should also be deferred where there is an active inflammatory process such as pimples, hives, rashes or cysts, until it has resolved.

Cómo funciona Revanesse Versa™+ ​

Versa+ is injected into the dermis using a variety of techniques, placing a small portion of the gel beneath a crease or wrinkle in the skin; the augmentation of the tissue produces a smoothing effect at the surface. The hyaluronic acid is a naturally occurring substance produced by bacteria and purified for use as an injectable soft tissue filler. Because the gel is bioresorbable, the correction is temporary rather than permanent. The 0.3% lidocaine is present for injection comfort.

Por qué comprar en Allpara

Allpara ofrece productos REVANESSE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

What clinical evidence supports Revanesse Versa+?

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.

Is Versa+ FDA approved?

Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
REVANESSE
Laboratorio
Prollenium Medical Technologies Inc.
SKU
11119
Formato
2 x 1,2 mL
Origen
Canadá
Indicación
Facial line smoothing and volume enhancement
Uso
Professional dermal filler, for patients 22+
/ Detalles del producto

El expediente completo

Revanesse Versa™+ is a hyaluronic acid injectable by Prollenium Medical Technologies, developed to correct facial wrinkles and folds that are moderate to severe. Qualified medical professionals use it in adults aged 22 years and older to treat facial wrinkles and folds, for example nasolabial folds. The product contains 25 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine and is intended for professional use. It comes in pre-filled syringes, including a 1.2 mL configuration, and is FDA approved in the United States.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

Prollenium Medical Technologies Inc., país de origen Canadá.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

What clinical evidence supports Revanesse Versa+?

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.

Is Versa+ FDA approved?

Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

What clinical evidence supports Revanesse Versa+?
A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.
Is Versa+ FDA approved?
Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.
/ FAQ

Preguntas frecuentes

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.
Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

Más productos de Prollenium Medical Technologies

Ver laboratorio

Alternativas para la clínica

Todos los productos

Revanesse Versa™+

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Revanesse Versa™+ is a hyaluronic acid injectable by Prollenium Medical Technologies, developed to correct facial wrinkles and folds that are moderate to severe. Qualified medical professionals use it in adults aged 22 years and older to treat facial wrinkles and folds, for example nasolabial folds. The product contains 25 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine and is intended for professional use. It comes in pre-filled syringes, including a 1.2 mL configuration, and is FDA approved in the United States.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

Principales ventajas de Revanesse Versa™+

  • Bioresorbable cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
  • Indicated for moderate to severe facial wrinkles and folds, such as nasolabial folds
  • Placed in the mid to deep dermis
  • FDA approved for the cosmetic treatment of facial wrinkles and creases
  • Supported by a randomised, multicentre, double-blind split-face study of 100 patients
  • Delivered in pre-filled disposable glass syringes, two 1.2 mL per box with two sterile needles
Información clave
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origen Canada
Certificación FDA approved
Composición Bioresorbable cross-linked hyaluronic acid 25 mg/mL containing 0.3% lidocaine
Volumen / Tamaño 1.2 ml
Envase 2 pre-filled disposable glass syringes x 1.2 mL, with two sterile needles
Tipo de uso Professional use only - injectable dermal filler for facial wrinkle smoothing, in patients 22 years of age and older
Profundidad de inyección Mid to deep dermis. Intended for intradermal use only and must not be injected into blood vessels.

Indicaciones y uso profesional

Indicaciones principales

  • Correction of moderate to severe facial wrinkles and folds
  • Nasolabial folds

Uso profesional

For professional use. Revanesse Versa+ is injected by qualified, trained doctors into the dermis of the patient, and is not for retail sale or self-administration. It is intended for intradermal use only and must not be injected into blood vessels: unintentional intravascular injection is rare but its complications can be serious and may be permanent, including vision abnormalities, blindness, stroke, temporary scabs and permanent scarring of the skin. Stop immediately and seek specialist assessment if the patient shows changes in vision, signs of a stroke, white appearance of the skin, or unusual pain during or shortly after treatment. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing, and confirm the box seal is unbroken and the product in date before use.

Zonas de tratamiento

  • Face
  • Nasolabial folds

Perfil del paciente

Indicated for adults 22 years of age or more seeking correction of moderate to severe facial wrinkles and folds. It should not be used in patients who are pregnant or breastfeeding, as safety in these groups has not been studied; who have a history of hypertrophic scarring or keloid formation; who have evidence of scars at the intended treatment sites; who have acne or other inflammatory skin diseases such as rosacea, seborrhoeic dermatitis or psoriasis; or who have an allergic history including severe allergic reactions, atopy, allergy to hyaluronic acid products, or allergy to streptococcal proteins. Treatment should also be deferred where there is an active inflammatory process such as pimples, hives, rashes or cysts, until it has resolved.

Cómo funciona Revanesse Versa™+ ​

Versa+ is injected into the dermis using a variety of techniques, placing a small portion of the gel beneath a crease or wrinkle in the skin; the augmentation of the tissue produces a smoothing effect at the surface. The hyaluronic acid is a naturally occurring substance produced by bacteria and purified for use as an injectable soft tissue filler. Because the gel is bioresorbable, the correction is temporary rather than permanent. The 0.3% lidocaine is present for injection comfort.

Por qué comprar en Allpara

Allpara ofrece productos REVANESSE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

What clinical evidence supports Revanesse Versa+?

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.

Is Versa+ FDA approved?

Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

Más productos de Prollenium Medical Technologies

Ver el laboratorio →

Revanesse Versa™+ is a hyaluronic acid injectable by Prollenium Medical Technologies, developed to correct facial wrinkles and folds that are moderate to severe. Qualified medical professionals use it in adults aged 22 years and older to treat facial wrinkles and folds, for example nasolabial folds. The product contains 25 mg/mL of cross-linked hyaluronic acid with 0.3% lidocaine and is intended for professional use. It comes in pre-filled syringes, including a 1.2 mL configuration, and is FDA approved in the United States.

*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.

Prollenium Medical Technologies Inc., país de origen Canadá.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

What clinical evidence supports Revanesse Versa+?

A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.

Is Versa+ FDA approved?

Yes. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.